Adjuncts and alternatives to oxime therapy in organophosphate poisoning - Is there evidence of benefit in human poisoning? A review

Anaesthesia and Intensive Care

Volumn 36, Issue 3, 2008, Pages

  Peter, J V ^a   Moran, J L ^a   Pichamuthu, K ^a   Chacko, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; ATROPINE; CLONIDINE; DIAZEPAM; GLYCOPYRRONIUM BROMIDE; MAGNESIUM; MAGNESIUM SULFATE; ORGANOPHOSPHATE; OXIME; PRALIDOXIME; ANTIDOTE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE REACTIVATOR; ORGANOPHOSPHORUS COMPOUND;

ALKALINIZATION; ARTICLE; BIOREMEDIATION; HEMOPERFUSION; HUMAN; INTOXICATION; NONHUMAN; SKIN DECONTAMINATION; STOMACH LAVAGE; ANIMAL; DRUG ANTAGONISM; META ANALYSIS; REVIEW;

ANIMALS; ANTIDOTES; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE REACTIVATORS; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; OXIMES; POISONING;

EID: 44449178279     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Kar N. Lethality of suicidal organophosphorus poisoning in an Indian population: exploring preventability. Ann Gen Psychiatry 2006; 5:17
2. Watson WA, Litovitz TL, Rodgers GC Jr, Klein-Schwartz W, Reid N, Youniss J et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666
3. Nozaki H, Aikawa N, Shinozawa Y, Hori S, Fujishima S, Takuma K et al. Sarin poisoning in Tokyo subway. Lancet 1995; 345:980-981
4. Peter JV, Cherian AM. Organic insecticides. Anaesth Intensive Care 2000; 28:11-21
5. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: An evaluation using meta-analytic techniques. Crit Care Med 2006; 34:502-510
6. Rahimi R, Nikfar S, Abdollahi M. Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Hum Exp Toxicol 2006; 25:157-162
7. Peter JV, Moran JL, Sudarsanam TD, Graham P. High-dose pralidoxime for organophosphorus poisoning. Lancet 2007; 369:1425-1426
8. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 2006; 368:2136-2141
9. Guven M, Sungur M, Eser B, Sari I, Altuntas S. The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning. J Toxicol Clin Toxicol 2004; 42:617-623
10. Keenan SP, Sinuff T, Cook DJ, Hill NS. Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature. Ann Intern Med 2003; 138:861-870
11. Phillips B, Ball C, Sackett DL et al. Oxford Centre for Evidence-based Medicine: Levels of Evidence. From http://www.cebm.net/index.aspx?o=1025 Accessed November 2007
12. Altintop L, Aygun D, Sahin H, Doganay Z, Guven H, Bek Y et al. In acute organophosphate poisoning, the efficacy of hemoperfusion on clinical status and mortality. J Intensive Care Med 2005; 20:346-350
13. Martinez-Chuecos J, del Carmen Jurado M, Paz Gimenez M, Martinez D, Menendez M. Experience with hemoperfusion for organophosphate poisoning. Crit Care Med 1992; 20:1538-1543
14. Peng A, Meng F, Sun L, Ji ZS, Li YH. Therapeutic efficacy of charcoal hemoperfusion in patients with acute severe dichlorvos poisoning. Acta Pharmacol Sin 2004; 25:15-21
15. Roberts D, Buckley NA. Alkalinisation for organophosphorus pesticide poisoning. Cochrane Database Syst Rev 2005; 25:CD004897
16. Pajoumand A, Shadnia S, Rezaie A, Abdi M, Abdollahi M. Benefits of magnesium sulphate in the management of acute human poisoning by organophosphorus insecticides. Hum Exp Toxicol 2004; 23:565-569
17. Bardin PG, Van Eeden SF. Organophosphate poisoning: grading the severity and comparing treatment between atropine and glycopyrrolate. Crit Care Med 1990; 18:956-960
18. Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED et al. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. Basic Clin Pharmacol Toxicol 2005; 97:35-38
19. Wheeler-Usher DH, Wanke LA, Bayer MJ. Gastric emptying. Risk versus benefit in the treatment of acute poisoning. Med Toxicol 1986; 1:142-153
20. Eddleston M, Haggalla S, Reginald K, Sudarshan K, Senthilkumaran M, Karalliedde L et al. The hazards of gastric lavage for intentional self-poisoning in a resource poor location. Clin Toxicol (Phila) 2007; 45:136-143
21. Veale JA, Kulig K. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: Gastric lavage. J Toxicol Clin Toxicol 2004; 42:933-943
22. Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005; 157:167-171
23. Rosenberg Y, Luo C, Ashani Y, Doctor BP, Fischer R, Wolfe G et al. Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase. Life Sci 2002; 72:125-134
24. Saxena A, Sun W, Luo C, Doctor BP. Human serum butyrylcholinesterase: In vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 2005; 157-158:199-203
25. Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet 2008; 371:597-607
26. Guven M, Sungur M, Eser B. The effect of plasmapheresis on plasma cholinesterase in a patient with organophosphate poisoning. Hum Exp Toxicol 2004; 23:365-368
27. Fulton JA, Bouchard NC, Becker ML, Gertz S, Hoffmann RS. FFP in organophosphate poisoning: what's the secret ingredient? Clin Toxicol (Phila) 2005; 43:215
28. Peeples ES, Schopfer LM, Duysen EG, Spaulding R, Voelker T, Thompson CM et al. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol Sci 2005; 83:303-312
29. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med 2003; 10:1303-1306
30. Eddleston M, Buckley NA, Checketts H, Senarathna L, Mohamed F, Sheriff MH et al. Speed of initial atropinisation in significant organophosphate pesticide poisoning - a systematic comparison of recommended regimens. J Toxicol Clin Toxicol 2004; 42:865-875
31. Robenshtok E, Luria S, Tashma Z, Hourvitz A. Adverse reaction to atropine and the treatment of organophosphate intoxication. Isr Med Assoc J 2002; 4:535-539
32. Choi PT, Quinonez LG, Cook DJ, Baxter F, Whitehead L. The use of glycopyrrolate in a case of intermediate syndrome following acute organophosphate poisoning. Can J Anaesth 1998; 45:337-340
33. Bradley RJ. Calcium or magnesium concentration affects the severity of organophosphate-induced neuromuscular block. Eur J Pharmacol 1986; 127:275-278
34. Singh G, Avasthi G, Khurana D, Whig J, Mahajan R. Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium. Electroencephalogr Clin Neurophysiol 1998; 107:140-148
35. Del Castillo J, Engbaek L. The nature of the neuromuscular block produced by magnesium. J Physiol 1954; 124:370-384
36. Kulick DL, Hong R, Ryzen E, Rude RK, Rubin JN, Elkayam U et al. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of cardiac disease. Am Heart J 1988; 115:367-373
37. DiCarlo LA, Morady F, de Buitleir M, Krol RB, Schurig L, Annesley TM. Effects of magnesium sulphate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 1986; 7:1356-1362
38. Moran JL, Gallagher J, Peake SL, Cunningham N, Salagaras M, Leppard P. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med 1995; 23:1816-1824
39. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990; 65:1397-1399
40. Kaye P, O'Sullivan I. The role of magnesium in the emergency department. Emerg Med J 2002; 19:288-291
41. Brill DM, Maisel AS, Prabhu R. Polymorphic ventricular tachycardia and other complex arrhythmias in organophosphate insecticide poisoning. J Electrocardiol 1984; 17:97-102
42. Lyzhnikov EA, Savina AS, Shepelev VM. [Pathogenesis of disorders of cardiac rhythm and conductivity in acute organophosphate insecticide poisoning] Russian. Kardiologiia 1975; 15:126-129
43. Chuang FR, Jang SW, Lin JL, Chem MS, Chen JB, Hsu KT. QTc prolongation indicates a poor prognosis in patients with organophosphate poisoning. Am J Emerg Med 1996; 14:451-453
44. Saadeh AM, Farsakh NA, al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart 1997; 77:461-464
45. Teague B, Peter JV, O'Fathartaigh M, Peisach AR. An unusual cause for cardiac arrest. Crit Care Resusc 1999; 1:362-365
46. Roth A, Zellinger I, Arad M, Atsmon J. Organophosphates and the heart. Chest 1993; 103:576-582
47. Petroianu G, Toomes LM, Petroianu A, Bergler W, Rufer R. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini-pigs. J Appl Toxicol 1998; 18:293-298
48. Wang MH, Tseng CD, Bair SY. QT interval prolongation and pleomorphic ventricular tachyarrhythmia ('Torsade de pointes') in organophosphate poisoning: report of a case. Hum Exp Toxicol 1998; 17:587-590
49. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial. A randomised placebo-controlled trial. Lancet 2002; 359:1877-1890
50. McDonough JH Jr, Clark TR, Slone TW Jr, Zoeffel D, Brown K, Kim S et al. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology 1998; 19:381-391
51. Rickett DL, Glenn JF, Beers ET. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 1986; 7:225-236
52. Chang FC, Foster RE, Beers ET, Rickett DL, Filbert MG. Neurophysiological concomitants of soman-induced respiratory depression in awake, behaving guinea pigs. Toxicol Appl Pharmacol 1990; 102:233-250
53. Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med 2003; 10:295-298
54. Sivilotti ML, Bird SB, Lo JC, Dickson EW. Multiple centrally acting antidotes protect against severe organophosphate toxicity. Acad Emerg Med 2006; 13:359-364
55. Newmark J. The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Neurology 2004; 62:1590-1596
56. Eddleston M, Mohamed F, Davies JO, Eyer P, Worek F, Sheriff MH et al. Respiratory failure in acute organophosphate pesticide self-poisoning. QJM 2006; 99:513-522
57. Silinsky EM. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction. J Physiol 2004; 558:389-401
58. Ito H, Hosoya Y, Inanobe A, Tomoike H, Endoh M. Acetylcholine and adenosine activate the G protein-gated muscarinic K+ channel in ferret ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 1995; 351:610-617
59. Van Helden HP, Groen B, Moor E, Westerink BH, Bruijnzeel PL. New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol 1998; 21 (Suppl 1):171-181
60. Bueters TJ, Groen B, Danhof M, Ijzerman AP, Van Helden HP. Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication. Arch Toxicol 2002; 76:650-656
61. Magri V, Buccafusco JJ, Aronstam RS. Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine. Toxicol Appl Pharmacol 1988; 95:464-473
62. Buccafusco JJ, Graham JH, Aronstam RS. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection offered by clonidine. Pharmacol Biochem Behav 1988; 29:309-313
63. Buccafusco JJ, Li W. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition. Res Commun Chem Pathol Pharmacol 1992; 75:85-98
64. Gultekin F, Ozturk M, Akdogan M. The effect of organophosphate insecticide chlorpyrifos-ethyl on lipid peroxidation and antioxidant enzymes (in vitro). Arch Toxicol 2000; 74:533-538
65. Yurumez Y, Cemek M, Yavuz Y, Birdane YO, Buyukokuroglu ME. Beneficial effect of N-acetylcysteine against organophosphate toxicity in mice. Biol Pharm Bull 2007; 30:490-494
66. Nenov VD, Marinov P, Sabeva J, Nenov DS. Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant 2003; 18 (Suppl 5):v56-58
67. Eigenberg DA, Pazdernik TL, Doull J. Hemoperfusion and pharmacokinetic studies with methamidophos in the rat. Fundam Appl Toxicol 1983; 3:496-501
68. Monhart V, Fusek J, Brndiar M, Tlustakova M. Use of hemoperfusion in experimental intoxication with nerve agents. Artif Organs 1994; 18:770-772
69. Okonek S. Probable progress in the therapy of organophosphate poisoning: extracorporeal hemodialysis and hemoperfusion. Arch Toxicol 1976; 35:221-227
70. Sudarsanam TD, Pichamuthu K, Zachariah A, John G. Oximes in acute organophosphate poisoning. Crit Care Med 2006; 34:2265
71. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L et al. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005; 366:1452-1459
72. Nagler J, Braeckman RA, Willems JL, Verpooten GA, De Broe ME. Combined hemoperfusion-hemodialysis in organophosphate poisoning. J Appl Toxicol 1981; 1:199-201
73. Shalkham AS, Kirrane BM, Hoffman RS, Goldfarb DS, Nelson LS. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 2006; 48:239-241
74. Jeevarathinam K, Ghosh AK, Srinivasan A, Das Gupta S. Pharmacokinetics of pralidoxime chloride and its correlation to therapeutic efficacy against diisopropyl fluorophosphate intoxication in rats. Pharmazie 1988; 43:114-115
75. Stefanovic D, Antonijevic B, Bokonjic D, Stojiljkovic MP, Milovanovic ZA, Nedeljkovic M. Effect of sodium bicarbonate in rats acutely poisoned with dichlorvos. Basic Clin Pharmacol Toxicol 2006; 98:173-180
76. Cordoba D, Cadavid S, Angulo D, Ramos I. Organophosphate poisoning: modifications in acid base equilibrium and use of sodium bicarbonate as an aid in the treatment of toxicity in dogs. Vet Hum Toxicol 1983; 25:1-3
77. Russell AJ, Erbeldinger M, DeFrank JJ, Kaar J, Drevon G. Catalytic buffers enable positive-response inhibition-based sensing of nerve agents. Biotechnol Bioeng 2002; 77:352-357
78. Montain SJ, Smith SA, Mattot RP, Zientara GP, Jolesz FA, Sawka MN. Hypohydration effects on skeletal muscle performance and metabolism: a 31P-MRS study. J Appl Physiol 1998; 84:1889-1894
79. Beekley MD, Cullom DL, Brechue WF. Hypercapnic impairment of neuromuscular function is related to afferent depression. Eur J Appl Physiol 2004; 91:105-110
80. Petroianu G, Karcher B, Kern N, Hardt F, Helfrich U, Rufer R. L-lactate reduces in vitro the inhibition of butyrylcholinesterase (BChE) by paraoxon (E 600). J Appl Toxicol 1999; 19:329-336
81. Petroianu G, Beha U, Roth C, Bergler W, Rufer R. L-lactate protects in vitro acetylcholinesterase (AChE) from inhibition by paraoxon (E 600). J Appl Toxicol 2000; 20:249-257
82. Balali-Mood M, Ayati M, Ali-Akbarian H. Effect of high doses of sodium bicarbonate in acute organophosphorus pesticide poisoning. Clin Toxicol (Phila) 2005; 43:571-574
83. Singh BK, Walker A. Microbial degradation of organophosphorus compounds. FEMS Microbiol Rev 2006; 30:428-471
84. Peter JV, Moran JL, Graham PL. Advances in the management of organophosphate poisoning. Expert Opin Pharmacother 2007; 8:1451-1464